Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Morris

Showing results (351-360 of 435) with videos related to

Pageof 44
Sort By:
In Vivo (Athens, Greece)|April 28, 2022
Cost-effectiveness of Iterative Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal CarcinomatosisJames R M Colbourne, Sam T Alhayo, Beeshman Nandakumar, et al.
World Journal of Surgical Oncology|July 23, 2025
Overall survival post secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent colorectal cancer with peritoneal metastasesRaymond Hayler, Celine Garrett, Jessica Guo, et al.
Laboratory Animals|June 14, 2013
Streptozotocin is equally diabetogenic whether administered to fed or fasted miceZunaira Z Chaudhry, David L Morris, Dan R Moss, et al.
Journal of Surgical Oncology|July 17, 2019
Long-term survival outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy: Single-institutional experience with 1225 casesLee Shyang Kyang, Nayef A Alzahrani, Sarah J Valle, et al.
Pleura and Peritoneum|June 12, 2023
Overall survival and morbidity are not associated with advanced age for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a single centre experienceErnest Cheng, Raphael Shamavonian, Jasmine Mui, et al.
Pathology Oncology Research : POR|April 30, 2009
Differential expression of Ki-67 and sex steroid hormone receptors between genders in peritoneal mesotheliomaTerence C Chua, Peng Yao, Javed Akther, et al.
Journal of Surgical Oncology|January 3, 2013
Secondary cytoreductive surgery and peri-operative intraperitoneal chemotherapy for peritoneal recurrence of colorectal and appendiceal peritoneal carcinomatosis following prior primary cytoreductionYvonne L B Klaver, Terence C Chua, Victor J Verwaal, et al.
American Journal of Translational Research|June 15, 2022
A novel method for potentiation of chemotherapy in soft tissue sarcomas with BromAcLillian Dong, Kevin Ke, Samina Badar, et al.
Annals of Surgery|December 31, 2009
Evaluation of the cost-effectiveness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (peritonectomy) at the St George Hospital peritoneal surface malignancy programTerence C Chua, Samantha Martin, Akshat Saxena, et al.
Annals of Surgical Oncology|July 12, 2019
Short- and Long-Term Outcomes of Patients Requiring Gastrectomy During Cytoreductive Surgery and Intraperitoneal Chemotherapy for Lower-Gastrointestinal Malignancies: A Propensity Score-Matched AnalysisBhavneet Singh, Oliver M Fisher, Gurkirat Singh, et al.
Pageof 44

Showing results (351-360 of 435) with videos related to

Sort By:
Pageof 44
In Vivo (Athens, Greece)|April 28, 2022
Cost-effectiveness of Iterative Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal CarcinomatosisJames R M Colbourne, Sam T Alhayo, Beeshman Nandakumar, et al.
World Journal of Surgical Oncology|July 23, 2025
Overall survival post secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent colorectal cancer with peritoneal metastasesRaymond Hayler, Celine Garrett, Jessica Guo, et al.
Laboratory Animals|June 14, 2013
Streptozotocin is equally diabetogenic whether administered to fed or fasted miceZunaira Z Chaudhry, David L Morris, Dan R Moss, et al.
Journal of Surgical Oncology|July 17, 2019
Long-term survival outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy: Single-institutional experience with 1225 casesLee Shyang Kyang, Nayef A Alzahrani, Sarah J Valle, et al.
Pleura and Peritoneum|June 12, 2023
Overall survival and morbidity are not associated with advanced age for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a single centre experienceErnest Cheng, Raphael Shamavonian, Jasmine Mui, et al.
Pathology Oncology Research : POR|April 30, 2009
Differential expression of Ki-67 and sex steroid hormone receptors between genders in peritoneal mesotheliomaTerence C Chua, Peng Yao, Javed Akther, et al.
Journal of Surgical Oncology|January 3, 2013
Secondary cytoreductive surgery and peri-operative intraperitoneal chemotherapy for peritoneal recurrence of colorectal and appendiceal peritoneal carcinomatosis following prior primary cytoreductionYvonne L B Klaver, Terence C Chua, Victor J Verwaal, et al.
American Journal of Translational Research|June 15, 2022
A novel method for potentiation of chemotherapy in soft tissue sarcomas with BromAcLillian Dong, Kevin Ke, Samina Badar, et al.
Annals of Surgery|December 31, 2009
Evaluation of the cost-effectiveness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (peritonectomy) at the St George Hospital peritoneal surface malignancy programTerence C Chua, Samantha Martin, Akshat Saxena, et al.
Annals of Surgical Oncology|July 12, 2019
Short- and Long-Term Outcomes of Patients Requiring Gastrectomy During Cytoreductive Surgery and Intraperitoneal Chemotherapy for Lower-Gastrointestinal Malignancies: A Propensity Score-Matched AnalysisBhavneet Singh, Oliver M Fisher, Gurkirat Singh, et al.
Pageof 44